System Transmission

Top Signal

100#1 JOB

Activity

2165Ripe

+921 today

System

Livenow

Terminal Asset View

stockNASDAQ

ASMB

$28.12-0.65%

Assembly Biosciences Inc. - Common Stock

Neutral

Official Site

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

8Neutral

Live Analysis Active

Company Mission

Assembly Biosciences researches and develops antiviral medications, specifically targeting hepatitis B and C viruses that cause liver infections. The company works on creating treatments that could help patients manage these chronic conditions better. It makes money through partnerships with larger pharmaceutical companies for research funding and could earn revenue from future drug sales if its treatments receive approval.

ASM

Industry Context

Assembly Biosciences operates in the biotechnology sector, which focuses on developing medical treatments through scientific research. Biotech companies often experience significant price movements when they announce clinical trial results or regulatory approvals for their experimental drugs.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

25Matrix

Market Momentum

47.7— Holding Steady

Trend Strength

25— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

0.7x— Normal Volume

Today's Change

-0.65%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing ASMB across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 02:34 AM UTC

As-of 03-15-2026 02:19 UTC

Develops antiviral drugs that fight hepatitis B and makes money by licensing these treatments to pharmaceutical companies.

Weekly price swings are getting smaller near recent levels, suggesting the Stock may be preparing for a larger move soon showing consolidation.

Biotech sector volatility often creates opportunities when stocks tighten like this, so watch for a breakout from this compressed pattern.

Educational only. Not investment advice.

Precision Intelligence Model

Live Terminal Stream

Loading chart...